Kenkre G Mahesh, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 120 N Main St, Suite 201, Attleboro, MA 02703 Phone: 508-222-8444 Fax: 508-226-3713 |
Richard C Statman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 28 Sturdy St, Attleboro, MA 02703 Phone: 508-226-7788 |
Dr. Andrew James Tompkins, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 Emory St, Attleboro, MA 02703 Phone: 774-643-1790 Fax: 774-643-1788 |
News Archive
A new report has shown that one fifth of all girls aged between 17 and 19 years and a tenth of boys in the same age group in England are suicidal or have tried to harm themselves.
Did women and men contribute equally to the lineage of contemporary populations? Did our ancestors, Homo sapiens, lean more toward polygamy or monogamy? To answer these questions, Dr. Damian Labuda, an investigator at the Sainte-Justine University Hospital Research Center and a professor at the Department of Pediatrics of the Universit- de Montr-al, headed a team that analyzed genomic data from three population samples of African, Asian and European origin. The study's findings are published in the most recent issue of the American Journal of Human Genetics.
The promise of earlier detection of diseases such as Alzheimer's is welcome news to the millions of families in the United States already affected by the various types of dementia. Emerging techniques such as spinal taps have shown success, but they are not effective for everyone.
The OPDQ is pleased that March has once again been designated as Nutrition Month. Across Quebec and the rest of Canada, dieticians/nutritionists will be holding events and activities aimed at raising public awareness about the importance of a healthful diet and teaching people how to maintain or improve their health by eating right.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
› Verified 1 days ago